Is Martin Shkreli blogging from prison?

Say what you will about Martin Shkreli, but the guy appears to have a relentless resilience to be heard. A few months into his prison sentence at Fort Dix, Shkreli might be blogging from his cell.

That’s according to activity on this site — — which saw its first entry posted yesterday. Although it’s still unclear if the blog is genuine, the first post was written in Shkreli’s now-familiar wry voice and style. He shares his personal contact information, including an email address you can send questions to. His people will print the emails and “snail mail” them to Shkreli at the correctional facility, the post says.

I’ve reached out to Fort Dix, the prison where Shkreli is currently serving his 7-year sentence for securities fraud, to see if Shkreli can actually post blogs while incarcerated. What access does he have to the internet? In what circumstances would the facility interfere with his blogging? The institution took my call, but said it needed time to respond. I’m still waiting to hear back.

If the blog is indeed genuine, it seems Shkreli is determined to share his thoughts on industry matters. The first section of his first entry is commentary on bio stocks and industry news, with musings like the one below:

Novartis’ much-telegraphed sale of Alcon and the continued implosion of GE reminds us conglomerates are more out of fashion than probably at any point in the history of business. This flies in the face of mechanical logic, but practically makes sense. Finding good managers is hard (I’ve maybe found a very small handful of decent managers out of close to 1000 I’ve employed over the years) and conglomerates can only work if you have an engaged CEO (about 5% of CEOs) and engaged managers (less than 5%? less than 10%?), which probability tells you is far lower.

Then he outlines scientific papers he’s read from prison and adds notes on what he thinks about each. Last, he dedicates a few paragraphs to his personal life.

“I have around 38 months to go assuming no success on an appeal,” he wrote. “I spend most of my team [sic] reading. A newspaper misreported that I’m ‘buff’. This is not the case.”

He also writes that news outlets have misreported facts about his assets.

“Oh, the Wu-Tang album is still in my possession,” he wrote. “As are all of my assets.”

News writers reported back in March that US District Judge Kiyo Matsumoto ordered Shkreli to forfeit $7.36 million. But that order got stayed — as we reported — pending Shkreli’s appeal, which could take a year or so to wrap up.

The news of Shkreli’s blog was first noted by Christie Smythe, a legal journalist who’s writing a book about Shkreli. Follow the conversation via this tweet, and we’ll update this story once Fort Dix gets back to us:

Image: Martin Shkreli. SHUTTERSTOCK

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 51,300+ biopharma pros who read Endpoints News by email every day.

Free Subscription

VP Oncology Biology
Skyhawk Therapeutics Waltham, MA
Associate Director CMC
Elektroki Boston, MA
Director Process Development
Elektroki Boston, MA
Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT

Visit Endpoints Careers ->